Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
europe blog main
4
×
life sciences
national blog main
boston blog main
boston top stories
cancer
clinical trials
national top stories
black diamond therapeutics
crispr
deals
eli lilly
europe top stories
fda
national
roche
san francisco blog main
abbvie
acceleron pharma
acid sphingomyelinase deficiency
acquisitions
advanced therapies
allergan
alzheimer's disease
anika therapeutics
annovis bio
arcutis biotherapeutics
atmp
avexis
baricitinib
beam therapeutics
bill & melinda gates foundation
biofourmis
biointellisense
biopharma
bioprocess insider
biotechnology industry organization
bladder cancer
blueprint medicines
What
therapeutics
4
×
black
companies
diamond
gene
leading
therapy
access
advanced
approval
betting
billion
bio
biopharma
biotech
cancer
capacity
car
cell
clinic
consolidation
continue
crispr
deal
debut
diamond’s
drug
duchenne
eluded
falcon
fda
focus
historic
hopes
indication
ipo
lead
life
lines
mammoth
Language
unset
Current search:
xconomy.com
×
therapeutics
×
" europe blog main "
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
